Publicaciones en las que colabora con P. Esbrit Arguelles (9)

2017

  1. Oxidation inhibits PTH receptor signaling and trafficking

    Biochemical and Biophysical Research Communications, Vol. 482, Núm. 4, pp. 1019-1024

2010

  1. Comparative in vitro effects of soybean isoflavones and resveratrol on human osteoblastic cells

    Isoflavones: Biosynthesis, Occurrence and Health Effects (Nova Science Publishers, Inc.), pp. 181-194

2009

  1. Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells

    Life Sciences, Vol. 85, Núm. 11-12, pp. 421-430

2008

  1. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2

    Journal of Cellular Physiology, Vol. 217, Núm. 3, pp. 717-727

  2. Receptor activator of nuclear factor-κB ligand (RANKL) as a novel prognostic marker in prostate carcinoma

    Histology and Histopathology, Vol. 23, Núm. 6, pp. 709-715

2007

  1. Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: Relative chanqes or parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand

    Journal of Clinical Pathology, Vol. 60, Núm. 3, pp. 290-294

2006

  1. Diferentes dosis de los fitoestrógenos genisteína y daidzeína afectan de distinto modo a la viabilidad celular y a la expresión de factores implicados en el desarrollo del cáncer de próstata

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 15, Núm. 5, pp. 91-97

  2. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro

    Calcified Tissue International, Vol. 79, Núm. 5, pp. 360-369

2005

  1. Efectos moduladores de los fitoestrógenos sobre la diferenciación de osteoblastos humanos

    Mapfre medicina, Vol. 16, Núm. 3, pp. 174-183